Synmosa Biopharma Corp Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Synmosa Biopharma Corp

Watchlist Manager

Watchlist

Price: 30.55 TWD -2.24% Market Closed

Market Cap: NT$16.8B

S	Synmosa Biopharma Corp TPEX:4114	TW
	Botetourt Bankshares Inc OTC:BORT	US
	Graphite One Inc F:2JCA	CA
	Ab Dynamics PLC OTC:ABDDF	UK

Profitability Summary

Synmosa Biopharma Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

43%

Sustainable 3Y Average Gross Margin

43%

Gross Margin is Increasing

41% > 43%

Healthy Operating Margin

12%

Sustainable 3Y Average Operating Margin

13%

Operating Margin is Increasing

11% > 12%

Healthy Net Margin

13%

Sustainable 3Y Average Net Margin

13%

Net Margin is Increasing

11% > 13%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

7% > 4%

Low ROE

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.